Simultaneous Liver Transplantation and Sleeve Gastrectomy: First Reported Case in East Asia

Yang Liu,Meng-Yi Li,Li-Ying Sun,Lan Jin,Wei Qu,Jun Wang,Zhi-Jun Zhu,Zhong-Tao Zhang,Lin Wei

DOI: https://doi.org/10.1097/cm9.0000000000000421

IF: 6.133

2019-01-01

Chinese Medical Journal

Abstract:To The Editor: Bariatric surgery, as an effective treatment for performed, and thick veins were directly ligated. The start patients with morbid obesity and its related metabolic point of the gastric resection was 6 cm away from the diseases, is gaining increasing popularity.Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity associated withmorbidobesity.Growing evidence suggests thatpatients with non-alcoholic steatohepatitis are at high-risk of adverse outcomes such as cirrhosis and liver-related mortality. Liver function failure caused byNAFLD is predicted to become the most common reason for liver transplantation (LT) in the United States by 2025. The estimated prevalence of obesity is 20% to 30% in LT recipients in the United States. LT is the only radical treatment for end-stage liver disease. If patients with end-stage liver disease and morbid obesity cannot effectively control their body weight after LT, the donor liver will be at high-risk of NAFLD again. Simultaneous LT and sleeve gastrectomy (SG) may be performed for effectively controlling post-operative body weight and metabolic disorders in these patients. We present a case of simultaneousLTandSG for a patientwith end-stage liver disease and morbid obesity.